advertisement
11.15 Other drugs in relation to glaucoma (70)
Showing records 1 to 25
Display all abstracts in classification 11.15 Other drugs in relation to glaucoma
Search within classification 11.15 Other drugs in relation to glaucoma76771 Effect of subconjunctival Bevacizumab injection on the outcome of Ahmed glaucoma valve implantation: a randomized control trial
Miraftabi A
Clinical and Experimental Ophthalmology 2018; 0:
76480 Systemic Medication Associations with Presumed Advanced or Uncontrolled Primary Open-Angle Glaucoma
Zheng W
Ophthalmology 2018; 125: 984-993
76850 Use of Intravitreal Bevacizumab for the Treatment of Secondary Glaucoma Caused by Metastatic Iris Tumor
Aydin R
Journal of Glaucoma 2018; 27: e113-e116
76527 Netarsudil Ophthalmic Solution 0.02%: First Global Approval
Hoy SM
Drugs 2018; 78: 389-396
76528 Bilateral acute angle-closure glaucoma following tramadol subcutaneous administration
Mahmoud A
BMC Ophthalmology 2018; 18: 50
76227 Ginkgo biloba and its potential role in glaucoma
Kang JM
Current Opinions in Ophthalmology 2018; 29: 116-120
77001 Initial trabeculectomy with 5-fluorouracil with or without subconjunctival bevacizumab in the management of pseudoexfoliation glaucoma
Elgin U
International Ophthalmology 2019; 39: 1211-1217
77026 Gene expression changes in the retina after systemic administration of aldosterone
Ono A
Japanese Journal of Ophthalmology 2018; 62: 499-507
77143 Assessing the role of ranibizumab in improving the outcome of glaucoma filtering surgery and neovascular glaucoma
Katsanos A
Expert opinion on biological therapy 2018; 18: 719-724
76260 Anticlotting agents and the surgical management of glaucoma
Sozeri Y
Current Opinions in Ophthalmology 2018; 29: 185-189
77257 Tacrolimus inhibits proliferation and induces apoptosis by decreasing survivin in scar fibroblasts after glaucoma surgery
Wang XC
European review for medical and pharmacological sciences 2018; 22: 2934-2940
77258 Bilateral Angle Closure Following the Infusion of a Monoclonal Antibody to Treat Relapsing Multiple Myeloma
Lee A
Journal of Glaucoma 2018; 0:
77150 Systemic medication usage in glaucoma patients
Bower T
Canadian Journal of Ophthalmology 2018; 53: 242-245
76926 Inhibitory Effects of Angiotensin II Receptor Blockade on Human Tenon Fibroblast Migration and Reactive Oxygen Species Production in Cell Culture
Kim D; Pattamatta U
Translational vision science & technology 2018; 7: 20
76771 Effect of subconjunctival Bevacizumab injection on the outcome of Ahmed glaucoma valve implantation: a randomized control trial
Nilforushan N
Clinical and Experimental Ophthalmology 2018; 0:
76260 Anticlotting agents and the surgical management of glaucoma
Salim S
Current Opinions in Ophthalmology 2018; 29: 185-189
77001 Initial trabeculectomy with 5-fluorouracil with or without subconjunctival bevacizumab in the management of pseudoexfoliation glaucoma
Sen E
International Ophthalmology 2019; 39: 1211-1217
77026 Gene expression changes in the retina after systemic administration of aldosterone
Hirooka K
Japanese Journal of Ophthalmology 2018; 62: 499-507
76480 Systemic Medication Associations with Presumed Advanced or Uncontrolled Primary Open-Angle Glaucoma
Dryja TP
Ophthalmology 2018; 125: 984-993
77150 Systemic medication usage in glaucoma patients
Samek DA
Canadian Journal of Ophthalmology 2018; 53: 242-245
77143 Assessing the role of ranibizumab in improving the outcome of glaucoma filtering surgery and neovascular glaucoma
Gorgoli K
Expert opinion on biological therapy 2018; 18: 719-724
77258 Bilateral Angle Closure Following the Infusion of a Monoclonal Antibody to Treat Relapsing Multiple Myeloma
Greaves G
Journal of Glaucoma 2018; 0:
76227 Ginkgo biloba and its potential role in glaucoma
Lin S
Current Opinions in Ophthalmology 2018; 29: 116-120
77257 Tacrolimus inhibits proliferation and induces apoptosis by decreasing survivin in scar fibroblasts after glaucoma surgery
Wang T
European review for medical and pharmacological sciences 2018; 22: 2934-2940
76528 Bilateral acute angle-closure glaucoma following tramadol subcutaneous administration
Abid F
BMC Ophthalmology 2018; 18: 50
